Inventor · disambiguated record
Ming Yan
Also filed as: YAN MING · YAN MING-CHUNG
15 granted patents·16 pending applications·12 citations·filing 2004–2025
88Inventor score
Files withUNIV CALIFORNIA8CSL BEHRING GENE THERAPY INC5RAMPART BIOSCIENCE INC5CSL BEHRING LLC3LU YUNFENG2
Top patents by PatentIndex Score
31 records- 0182US10961537B2Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2018·Granted Mar 30, 2021·2 cites·27 claims
- 0279US9782357B2RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsulesUNIV CALIFORNIA·Filed 2013·Granted Oct 10, 2017·4 cites·18 claims
- 0378US10179112B2Viral vector nanocapsule for targeting gene therapy and its preparationUNIV CALIFORNIA·Filed 2013·Granted Jan 15, 2019·1 cites·17 claims
- 0476US9283194B2Methods for protease assisted protein deliveryTANG YI·Filed 2011·Granted Mar 15, 2016·3 cites·20 claims
- 0576US2024043845A1Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2023·Application pending·0 cites
- 0672US11253483B2Protease assisted native-protein delivery approach (PANDA)UNIV CALIFORNIA·Filed 2019·Granted Feb 22, 2022·0 cites·19 claims
- 0771US12473568B2Non-immunogenic circular, non-viral DNA vectorsRAMPART BIOSCIENCE INC·Filed 2025·Granted Nov 18, 2025·0 cites·27 claims
- 0870US12473567B2Non-immunogenic circular, non-viral DNA vectorsRAMPART BIOSCIENCE INC·Filed 2025·Granted Nov 18, 2025·0 cites·27 claims
- 0969US11795461B2Compositions and methods for treating beta-hemoglobinopathiesCSL BEHRING GENE THERAPY INC·Filed 2021·Granted Oct 24, 2023·0 cites·21 claims
- 1069US10426798B2Modulatable switch for selection of donor modified cellsCALIMMUNE INC·Filed 2018·Granted Oct 1, 2019·1 cites·17 claims
- 1168US11213548B2Modulatable switch for selection of donor modified cellsCSL BEHRING GENE THERAPY INC·Filed 2019·Granted Jan 4, 2022·0 cites·25 claims
- 1268US10016490B2Multiple-enzyme nanocomplexesLU YUNFENG·Filed 2012·Granted Jul 10, 2018·1 cites·12 claims
- 1366US2025146016A1Non-immunogenic circular, non-viral dna vectorsRAMPART BIOSCIENCE INC·Filed 2025·Application pending·0 cites
- 1466US2025146015A1Non-immunogenic circular, non-viral dna vectorsRAMPART BIOSCIENCE INC·Filed 2025·Application pending·0 cites
- 1564US2022072046A1Modulatable switch for selection of donor modified cellsCSL BEHRING GENE THERAPY INC·Filed 2021·Application pending·0 cites
- 1661US2020397712A1NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULESUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1760US2023339942A1Inhibitors of ubiquitin specific peptidase 22 (usp22) and uses thereof for treating diseases and disordersUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 1859US2024150737A1Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructsRAMPART BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1957US2022133859A1Oral delivery of enzymes by nanocapsules for targeted metabolism of alcohol or toxic metabolitesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2056US10568844B2RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsulesUNIV CALIFORNIA·Filed 2017·Granted Feb 25, 2020·0 cites·19 claims
- 2156US2019046461A1Viral vector nanocapsule for targeting gene therapy and its preparationUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 2255US2024238274A1Inhibitors of ubiquitin specific peptidase 22 (usp22) and uses thereof for treating disease and disordersUNIV NORTHWESTERN·Filed 2022·Application pending·0 cites
- 2353US2021322331A1Nanocapsules for the delivery of cell modulating agentsCSL BEHRING LLC·Filed 2021·Application pending·0 cites
- 2452US10434069B2Protease assisted native-protein delivery approach (PANDA)UNIV CALIFORNIA·Filed 2016·Granted Oct 8, 2019·0 cites·13 claims
- 2551US2004209315A1Methods to identify agents that increase or decrease UBP43 activity and methods for use of such agentsFiled 2004·Application pending·0 cites
- 2650US2021316013A1Haematopoietic stem cell-gene therapy for wiskott-aldrich syndromeCSL BEHRING LLC·Filed 2021·Application pending·0 cites
- 2747US2021340563A1Donor t-cells with kill switchCSL BEHRING LLC·Filed 2021·Application pending·0 cites
- 2841US9273246B2Triphenylene derivative and use thereofJIANGSU HECHENG DISPLAY TECH·Filed 2013·Granted Mar 1, 2016·0 cites·6 claims
- 2939US9289504B2Single protein nanocapsules for protein delivery with long-term effectLU YUNFENG·Filed 2010·Granted Mar 22, 2016·0 cites·14 claims
- 3038US2013065957A1Diclofenac salt of tramadolYUNG SHIN PHARM IND CO LTD·Filed 2012·Application pending·0 cites
- 3135US2016327551A1Sers nanoparticles and methods for using the sameBECTON DICKINSON CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ming Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →